Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing. [PDF]
HemasphereBuenache N +31 more
europepmc +1 more source
Spatiotemporal heterogeneity in non-small cell lung cancer: A paradigm shift from characterization to dynamic management (Review). [PDF]
Oncol LettCao L, Zhang W.
europepmc +1 more source
Circulating Biomarkers in Localized Anal Squamous Cell Carcinoma Across Treatment Timepoints: A Systematic Review. [PDF]
Cancers (Basel)Adeoye O +9 more
europepmc +1 more source
Genetics of mCRPC tracked in ctDNA [PDF]
Nature Reviews Clinical Oncology, 2016 openaire +1 more source
From Standard of Care to mRNA Cancer Vaccines and Spatial Architecture-Based Precision Therapy in PDAC: Challenges and Expectations. [PDF]
Cancers (Basel)Stea EX, Kydonakis N, Roukos DH.
europepmc +1 more source
ctDNA-guided precision therapy with trastuzumab deruxtecan plus pyrotinib in HER2-positive breast cancer brain metastases: a case report. [PDF]
Front OncolZhou D +7 more
europepmc +1 more source
Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study. [PDF]
J Immunother CancerCai G +20 more
europepmc +1 more source
ctDNA identified in patients with CUP [PDF]
Nature Reviews Clinical Oncology, 2017 openaire +1 more source
Classic Hodgkin Lymphoma Beyond the Lymph Node: A Systemic Immunobiological Paradigm. [PDF]
Cancers (Basel)Carbone A, Gloghini A.
europepmc +1 more source